CompletedNCT04726527

Clinical Evaluation of Florbetapir in Primary Progressive Aphasia

Studying Frontotemporal dementia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Chicago
Principal Investigator
Emily Rogalski, Ph.D
University of Chicago
Intervention
Florbetapir F 18(drug)
Enrollment
48 enrolled
Eligibility
18 years · All sexes
Timeline
20122017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04726527 on ClinicalTrials.gov

Other trials for Frontotemporal dementia

Additional recruiting or active studies for the same condition.

See all trials for Frontotemporal dementia

← Back to all trials